• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表皮生长因子受体、脱糖粘蛋白、基质金属蛋白酶和p53在大鼠和人胆管癌中的表达:胆管癌动物模型的评估

Expression of epidermal growth factor receptor, apomucins, matrix metalloproteinases, and p53 in rat and human cholangiocarcinoma: appraisal of an animal model of cholangiocarcinoma.

作者信息

Jan Yi-Yin, Yeh Ta-Sen, Yeh Jun-Nan, Yang Horng-Ren, Chen Miin-Fu

机构信息

Department of Surgery, Chang Gung Memorial Hospital, Chang Gung University, Taipei, Taiwan.

出版信息

Ann Surg. 2004 Jul;240(1):89-94. doi: 10.1097/01.sla.0000129492.95311.f2.

DOI:10.1097/01.sla.0000129492.95311.f2
PMID:15213623
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1356379/
Abstract

OBJECTIVE

We sought to determine the expression of molecular markers in an animal model of cholangiocarcinoma compared with those in human cholangiocarcinoma.

SUMMARY BACKGROUND DATA

Cholangiocarcinoma is a rare disease characterized by early intrahepatic and extrahepatic spread, which seriously limits the efficacy of surgery. Establishing an experimental model to study the cholangiocarcinogenesis is desirable.

METHODS

Sprague-Dawley rats weighing 300 +/- 50 g were used for the study group. The animals were given 0.3% thioacetamide in tap water continuously. Thirty mass-forming peripheral cholangiocarcinoma patients also were studied. Expression of epidermal growth factor receptor (EGFR), MUC1, MUC2, MUC5AC, MMP-2, MMP-9, and p53 in both human and experimental rat cholangiocarcinoma was examined using immunohistochemistry.

RESULTS

Using thioacetamide 0.3% as a hepatoxin to induce cholangiocarcinoma in rats, microfoci of cancerous cells were detected from 12 weeks, and all experimental rats displayed diffuse mass-forming cholangiocarcinoma after 24 weeks. EGFR was strongly expressed in 14 (47%) of 30 human cholangiocarcinoms and 24 (100%) of 24 rat cholangiocarcinomas, respectively. MUC1 was strongly expressed in all human and rat cholangiocarcinomas, whereas MUC2 and MUC5AC were focally and weakly expressed. MMP-2 and MMP-9 were strongly expressed in 22 (73%) of 30 human cholangiocarcinomas and 24 (100%) of 24 rat cholangiocarcinomas, respectively. p53 overexpression was detected in 9 (30%) of 30 human cholangiocarcinoma and none of the rat cholangiocarcinoma, respectively.

CONCLUSIONS

The expression of EGFR, apomucins, MMPs, and p53 in rat cholangiocarcinoma was strongly homologous to human cholangiocarcinoma. Thioacetamide-induced cholangiocarcinoma in rats provides an excellent model for investigating cholangiocarcinogenesis in vivo.

摘要

目的

我们试图确定胆管癌动物模型中分子标志物的表达,并与人类胆管癌中的表达进行比较。

总结背景数据

胆管癌是一种罕见疾病,其特征为早期肝内和肝外扩散,这严重限制了手术疗效。建立一个实验模型来研究胆管癌发生过程是很有必要的。

方法

体重300±50 g的Sprague-Dawley大鼠用于研究组。动物连续饮用含0.3%硫代乙酰胺的自来水。还对30例形成肿块的周围型胆管癌患者进行了研究。采用免疫组织化学法检测人及实验大鼠胆管癌中表皮生长因子受体(EGFR)、MUC1、MUC2、MUC5AC、基质金属蛋白酶-2(MMP-2)、基质金属蛋白酶-9(MMP-9)和p53的表达。

结果

以0.3%硫代乙酰胺作为肝毒素诱导大鼠胆管癌,12周时检测到癌细胞微灶,24周后所有实验大鼠均表现为弥漫性肿块形成型胆管癌。EGFR在30例人类胆管癌中的14例(47%)和24例大鼠胆管癌中的24例(100%)中均有强表达。MUC1在所有人类和大鼠胆管癌中均有强表达,而MUC2和MUC5AC呈局灶性弱表达。MMP-2和MMP-9分别在30例人类胆管癌的22例(73%)和24例大鼠胆管癌的24例(100%)中强表达。p53过表达分别在30例人类胆管癌的9例(30%)中检测到,而在大鼠胆管癌中未检测到。

结论

大鼠胆管癌中EGFR、黏蛋白、基质金属蛋白酶和p53的表达与人类胆管癌高度同源。硫代乙酰胺诱导的大鼠胆管癌为体内研究胆管癌发生提供了一个良好的模型。

相似文献

1
Expression of epidermal growth factor receptor, apomucins, matrix metalloproteinases, and p53 in rat and human cholangiocarcinoma: appraisal of an animal model of cholangiocarcinoma.表皮生长因子受体、脱糖粘蛋白、基质金属蛋白酶和p53在大鼠和人胆管癌中的表达:胆管癌动物模型的评估
Ann Surg. 2004 Jul;240(1):89-94. doi: 10.1097/01.sla.0000129492.95311.f2.
2
The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.基质金属蛋白酶在肝内胆管癌、肝门部(克氏壶腹肿瘤)、肝外胆管中下段癌、胆囊癌和壶腹癌中的表达:基质金属蛋白酶在肿瘤进展和预后中的作用
Turk J Gastroenterol. 2009 Mar;20(1):41-7.
3
Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles.肝硬化中发生的胆管癌以及肝细胞-胆管细胞癌共同具有脱辅基粘蛋白谱。
Am J Clin Pathol. 1998 Mar;109(3):302-8. doi: 10.1093/ajcp/109.3.302.
4
Altered mucin gene expression in stone-containing intrahepatic bile ducts and cholangiocarcinomas.含结石的肝内胆管及胆管癌中粘蛋白基因表达的改变
Dig Dis Sci. 2001 Oct;46(10):2166-72. doi: 10.1023/a:1011906830301.
5
Liver fluke-associated and sporadic cholangiocarcinoma: an immunohistochemical study of bile duct, peribiliary gland and tumour cell phenotypes.肝吸虫相关性和散发性胆管癌:胆管、胆管周围腺体及肿瘤细胞表型的免疫组织化学研究
J Clin Pathol. 2006 Oct;59(10):1073-8. doi: 10.1136/jcp.2005.033712. Epub 2006 May 5.
6
c-erbB-2 protein is expressed in hepatolithiasis and cholangiocarcinoma.c-erbB-2蛋白在肝内胆管结石和胆管癌中表达。
Histopathology. 1998 Oct;33(4):325-31. doi: 10.1046/j.1365-2559.1998.00496.x.
7
[Expression of epidermal growth factor receptor, ErbB2 and matrix metalloproteinase-9 in hepatolithiasis and cholangiocarcinoma].[表皮生长因子受体、ErbB2及基质金属蛋白酶-9在肝内胆管结石及胆管癌中的表达]
Korean J Gastroenterol. 2005 Jan;45(1):52-9.
8
Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.MUC1和MUC2黏蛋白抗原在肝内胆管肿瘤中的表达:其与胆管癌新形态学分类的关系
Hepatology. 1999 Dec;30(6):1347-55. doi: 10.1002/hep.510300609.
9
Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma.表皮生长因子受体(ErbB)家族受体酪氨酸激酶在肝内胆管癌中的作用
World J Gastroenterol. 2008 Dec 14;14(46):7033-58. doi: 10.3748/wjg.14.7033.
10
[Expression of mucin glycoproteins and cytokeratins in intrahepatic cholangiocarcinoma].[黏蛋白糖蛋白和细胞角蛋白在肝内胆管癌中的表达]
Zhonghua Bing Li Xue Za Zhi. 2008 Nov;37(11):749-53.

引用本文的文献

1
Reflections on Drivers for the Emergence and Spread of Antimicrobial Resistant Bacteria Detected from Chickens reared on Commercial Layer Farms in Mukono District, Uganda.对乌干达穆科诺区商业蛋鸡养殖场饲养的鸡中检测到的抗菌药物耐药细菌出现和传播驱动因素的思考
Vet Med (Auckl). 2023 Dec 6;14:209-219. doi: 10.2147/VMRR.S418624. eCollection 2023.
2
Comprehensive Evaluation of Immune-Checkpoint DNA Cancer Vaccines in a Rat Cholangiocarcinoma Model.大鼠胆管癌模型中免疫检查点DNA癌症疫苗的综合评估
Vaccines (Basel). 2020 Nov 24;8(4):703. doi: 10.3390/vaccines8040703.
3
Evaluation of positive ductal margins of biliary tract cancer in intraoperative histological examination.术中组织学检查中胆管癌阳性切缘的评估
Oncol Lett. 2018 Nov;16(5):6677-6684. doi: 10.3892/ol.2018.9479. Epub 2018 Sep 21.
4
Synergistic antiproliferative effects of an mTOR inhibitor (rad001) plus gemcitabine on cholangiocarcinoma by decreasing choline kinase activity.雷帕霉素靶蛋白抑制剂(rad001)联合吉西他滨通过降低胆碱激酶活性对胆管癌的协同抗增殖作用。
Dis Model Mech. 2018 May 14;11(8):dmm033050. doi: 10.1242/dmm.033050.
5
Animal models of cholangiocarcinoma.胆管癌动物模型。
Biochim Biophys Acta Mol Basis Dis. 2019 May 1;1865(5):982-992. doi: 10.1016/j.bbadis.2018.03.026. Epub 2018 Apr 5.
6
Molecular Markers in the Pathogenesis of Cholangiocarcinoma: Potential for Early Detection and Selection of Appropriate Treatment.胆管癌发病机制中的分子标志物:早期检测及选择合适治疗方法的潜力
Gastroenterology Res. 2009 Jun;2(3):132-140. doi: 10.4021/gr2009.06.1299. Epub 2009 May 20.
7
EGFR Signaling in Liver Diseases.肝脏疾病中的表皮生长因子受体信号传导
Int J Mol Sci. 2015 Dec 29;17(1):30. doi: 10.3390/ijms17010030.
8
Liver carcinogenesis: rodent models of hepatocarcinoma and cholangiocarcinoma.肝癌发生机制:肝癌和胆管癌的啮齿动物模型。
Dig Liver Dis. 2013 Jun;45(6):450-9. doi: 10.1016/j.dld.2012.10.008. Epub 2012 Nov 22.
9
HER3 overexpression is a prognostic indicator of extrahepatic cholangiocarcinoma.HER3 过表达是肝外胆管癌的预后指标。
Virchows Arch. 2012 Nov;461(5):521-30. doi: 10.1007/s00428-012-1321-0. Epub 2012 Oct 2.
10
The role of the myofibroblast in tumor stroma remodeling.成纤维细胞在肿瘤基质重构中的作用。
Cell Adh Migr. 2012 May-Jun;6(3):203-19. doi: 10.4161/cam.20377. Epub 2012 May 1.

本文引用的文献

1
Liver Tumors in Rats Fed Thiourea or Thioacetamide.喂食硫脲或硫代乙酰胺的大鼠肝脏肿瘤
Science. 1948 Dec 3;108(2814):626-8. doi: 10.1126/science.108.2814.626.
2
Clinical outcomes and apomucin expression of intrahepatic cholangiocarcinoma according to gross morphology.根据大体形态学观察肝内胆管癌的临床结局及脱膜黏蛋白表达情况
J Am Coll Surg. 2002 Dec;195(6):782-9. doi: 10.1016/s1072-7515(02)01343-1.
3
Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document.胆管癌诊疗指南:共识文件
Gut. 2002 Nov;51 Suppl 6(Suppl 6):VI1-9. doi: 10.1136/gut.51.suppl_6.vi1.
4
Cyclooxygenase-2 and ERBB-2 in cholangiocarcinoma: potential therapeutic targets.胆管癌中的环氧化酶-2和表皮生长因子受体-2:潜在的治疗靶点。
Semin Liver Dis. 2002 Aug;22(3):303-13. doi: 10.1055/s-2002-34507.
5
ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions.人胆管癌中ERBB-2过表达与环氧合酶-2上调及风险状况
Hepatology. 2002 Aug;36(2):439-50. doi: 10.1053/jhep.2002.34435.
6
Intraductal papillary neoplasia of the liver associated with hepatolithiasis.与肝内胆管结石相关的肝内导管内乳头状瘤变
Hepatology. 2001 Oct;34(4 Pt 1):651-8. doi: 10.1053/jhep.2001.28199.
7
Cholangiocarcinoma and liver cirrhosis in relation to changes due to thioacetamide.硫代乙酰胺所致变化与胆管癌和肝硬化的关系
Mol Cell Biochem. 2000 May;208(1-2):1-10. doi: 10.1023/a:1007082515548.
8
[MUC genes: a superfamily of genes? Towards a functional classification of human apomucins].[黏蛋白基因:一个基因超家族?迈向人类去糖基化黏蛋白的功能分类]
J Soc Biol. 1999;193(1):85-99.
9
Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings.恶性肝门部胆管梗阻:磁共振胰胆管造影表现
Am J Gastroenterol. 2000 Feb;95(2):432-40. doi: 10.1111/j.1572-0241.2000.01763.x.
10
Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.MUC1和MUC2黏蛋白抗原在肝内胆管肿瘤中的表达:其与胆管癌新形态学分类的关系
Hepatology. 1999 Dec;30(6):1347-55. doi: 10.1002/hep.510300609.